Prescription magnetic pulses for FDA-cleared psychiatric and selected neurologic uses. TMS is not a consumer PEMF mat and is not a cognitive-enhancement gadget.
Transcranial magnetic stimulation (TMS) is a prescription procedure that uses a specialized coil to induce small electrical currents in a targeted cortical region. Repetitive TMS (rTMS) and related protocols are delivered in a clinic, usually without anesthesia. NIMH describes rTMS among FDA-authorized brain-stimulation therapies for specified mental disorders. Clearance belongs to an exact system, indication, age range, and protocol—not to a generic “brain magnet” category.
Device-specific FDA-cleared psychiatric uses include selected major depressive disorder protocols, often after inadequate response to medication, and obsessive-compulsive disorder on certain systems. Separate single-pulse devices have migraine indications. Accelerated and deep-coil protocols exist only when that model’s labeling supports them. TMS is not consumer PEMF. Wellness mats and low-intensity pulsed-field products differ in output, focal targeting, supervision, and evidence. A longevity menu that lists PEMF, tDCS, and TMS as interchangeable neuromodulation is incorrect.
A responsible course starts with a licensed psychiatric or neurologic diagnosis, a medication and suicide-risk review, and a safety screen for seizure history, implanted electronics, conductive cranial metal, pregnancy, and hearing protection. Motor-threshold mapping or device-specific targeting sets the dose. Sessions are outpatient. Common effects include scalp discomfort and headache. Seizure is uncommon but serious. Mania or mood destabilization can occur. Cognitive-enhancement marketing for healthy adults is not the labeled psychiatric use.
This page is for people offered clinic TMS or a look-alike wellness device. It does not rank centers and it does not promise remission or a cure. Ask for the manufacturer, model, clearance or authorization, intended use, supervising physician, and what happens if depression or OCD does not improve. Keep emergency pathways for suicidality, seizure, or acute neurologic symptoms. Off-label cognitive or “optimization” claims should be named as off-label, with uncertainty stated.
Provide a complete medication, supplement, and implant history, including any prior seizures or mood elevation. Arrange reliable transport if you are unsure how you will feel after the first sessions. Remove magnetic objects and follow clinic rules on sleep, alcohol, and missed doses. Bring contact information for the clinician who manages your depression or OCD. This is not a walk-in PEMF session.
Most people resume usual activity immediately. Scalp tenderness or headache can follow a session and often responds to simple measures your clinician approves. Hearing protection should be used during treatment. Seek emergency care for a seizure, sudden weakness, severe headache unlike your usual pattern, or worsening suicidal thinking. Do not treat agitation or mania as a sign the protocol is “working.”
Common effects include scalp discomfort and headache. Hearing injury is possible without protection. Seizure is rare but serious and depends on protocol and patient factors. Mania, anxiety, or mood worsening can occur. People with certain implants or cranial metal may be ineligible. The other harm is substitution: using a wellness PEMF product, or an off-label “optimization” series, instead of indicated psychiatric care for depression, OCD, or crisis symptoms.
NIMH: Brain Stimulation Therapies
https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapiesNIMH: Depression
https://www.nimh.nih.gov/health/topics/depressionFDA: Permits Marketing of TMS for Obsessive-Compulsive Disorder
https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-transcranial-magnetic-stimulation-treatment-obsessive-compulsive-disorderFDA 510(k) K083538: NeuroStar TMS for Major Depressive Disorder
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K083538PMC: FDA Milestones for TMS Devices
https://pmc.ncbi.nlm.nih.gov/articles/PMC8864803/© 2026 Longevity Clinic Finder. All rights reserved.
Designed by SMBPulse
Patients with a confirmed condition for which an exact TMS system and protocol are appropriate after licensed medical evaluation—typically selected depression or OCD. It is not for healthy people seeking generic cognitive enhancement, and it is not a consumer PEMF-mat substitute.
Explore nearby clinics, compare profiles, and find providers offering this treatment.
Find Clinics Near You© 2026 Longevity Clinic Finder. All rights reserved.
Designed by SMBPulse